KROS
Keros Therapeutics Inc
11.50$
+1.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -60.0% | +2,359.5% | -5.3% | +20.2% | +20.6% | +66.4% | -45.1% | |
| – | -65.0% | +2,899.1% | -6.1% | +13.7% | +21.5% | +69.6% | -46.4% | |
| – | -69.8% | +3,687.4% | -13.5% | +21.3% | +18.7% | +69.1% | -48.7% | |
| – | -69.8% | +3,687.4% | -13.5% | +21.3% | +18.7% | +69.1% | -48.7% | |
| – | – | -76.6% | +8,324.5% | -95.4% | +29.7% | +308.4% | +43.0% | |
| – | – | +94.2% | +107.5% | -127.5% | – | – | – | |
| – | +38.6% | -16.3% | -16.7% | +51.4% | – | – | – | |
| – | -62.4% | +40.3% | +56.4% | +143.1% | +28.8% | +17.2% | -21.3% | |
| – | -60.9% | +60.1% | +64.9% | +39.7% | +47.3% | +12.6% | -25.6% | |
| – | +126.5% | +12.5% | +103.8% | -47.2% | +120.9% | +96.8% | +21.7% | |
| – | +316.8% | +2.9% | +69.6% | -8.4% | +63.2% | -15.6% | -57.3% | |
| – | +107.2% | – | – | – | – | – | – | |
| – | -57.3% | +4,701.3% | -7.1% | +14.1% | +19.7% | +72.0% | -47.0% | |
| – | – | – | – | – | – | – | – | |
| – | +0.0% | +74.6% | +50.5% | +8.2% | +16.7% | +27.1% | +1.1% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.